Mar 31, 2014
Gilead Sciences Inc. is betting that some people will pay $1,000 a pill for its new medication against hepatitis C – $14,000 for a two-week course of the medication.
That’s the price the company has put on Sovaldi, a new drug that supposedly is better than current drugs in treating hepatitis.
Hepatitis C progressively destroys your liver, leading to your death if the disease continues. Sovaldi supposedly checks the disease in between 80 and 90 per cent of patients.
Money hungry vultures? You bet!
And one more proof that in capitalist society the health care you get depends on how much money you have!